Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCNY antisense RNA 1 (CCNY-AS1) is a long non-coding RNA transcribed from the antisense strand relative to the coding *CCNY* gene (Cyclin Y). As an antisense RNA, it may regulate *CCNY* expression or contribute to gene regulatory networks that impact cellular processes, but currently no direct biological function, disease role, or drug interaction is established for CCNY-AS1, and it is not considered a therapeutic target. Most published research on antisense RNAs indicates they frequently modulate target gene expression or chromatin states, mainly through transcriptional or epigenetic mechanisms, but no such specific evidence for CCNY-AS1 itself is present in current curated literature[2][3]. There is no indication of a misspelling or major error regarding CCNY-AS1; AL117336.3 is a valid alternative identifier for the same transcript. No specific functional classification such as "receptor," "enzyme," or "transporter" applies to CCNY-AS1, since it is a non-coding regulatory RNA. There are no reported drugs, mechanisms, biomarker utilities, or safety concerns directly associated with CCNY-AS1. This target should be considered a member of the long non-coding RNA family and *antisense RNA* sub-category, with a putative biological role in gene regulation (by analogy to other antisense lncRNAs), but lacking direct therapeutic relevance or actionable evidence[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCNY antisense RNA 1 (CCNY-AS1).